A Look At Jeffrey Ubben's Latest ValueAct Capital 13F

Loading...
Loading...

Jeffrey Ubben’s ValueAct Capital is a fund focused on long-term investments. It usually holds about 15 equity positions and changes only three or four of them for new ones each year.

In its latest 13F filing for the fourth quarter of 2014, the fund disclosed two new purchases, five additional acquisitions, four stake reductions and only one closing of a pre-existing position. Following these transactions, its equity portfolio is worth almost $16 billion.

Adds

  • Baker Hughes Incorporated BHI - 14,997,500 shares, worth more than $840 million
  • Halliburton Company HAL - 20,895,000 shares, worth about $821 million

Increases

  • Microsoft Corporation MSFT - 74,238,243
  • Valeant Pharmaceuticals Intl Inc VRX - 19,383,877 shares, up 2 percent
  • Twenty-First Century Fox Inc FOX – 30,300,000 shares, up 20 percent
  • Agrium Inc. AGU - 8,194,898 shares, up 57 percent
  • Allison Transmission Holdings, Inc. ALSN - 19,125,204 shares, up 6 percent
Loading...
Loading...

Decreases

  • Motorola Solutions Inc MSI - 17,588,576 shares, down 39 percent
  • Adobe Systems Incorporated ADBE - 16,006,753 shares, down 32 percent
  • CBRE Group Inc CBG - 31,322,230 shares, down 2 percent
  • Rockwell Collins, Inc. COL - 4,465,000 shares, down 59 percent

Exits

  • Twenty-First Century Fox Inc FOXA - 4,600,000 shares, which accounted for approximately 1 percent of the third quarter portfolio
Loading...
Loading...
Posted In: Long IdeasHedge FundsLegalTrading IdeasGeneralJeffrey UbbenValueAct Capital
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...